ORCL Ticker Curator

CapEx $50B FY26 scale-up incl Bloom 2.8GW fuel cells, massive layoffs, financing/restruct/CFO Maxson for OCI/AI; Health divestiture speculation

CapEx $50B FY26 scale-up incl Bloom 2.8GW fuel cells, massive layoffs, financing/restruct/CFO Maxson for OCI/AI; Health divestiture speculation

Key Questions

What is Oracle planning for its CapEx in FY26 and how does it involve Bloom Energy?

Oracle is scaling up CapEx to around $50B in FY26, including Bloom Energy's 2.8GW fuel cells as part of plans exceeding 10GW capacity, $156B in power needs, and $35B in data centers. This requires $45-50B in financing.

Who is Oracle's new CFO and what is the context of the FY26 restructuring?

Oracle appointed Maxson as CFO, with a $26M package from his previous role at Schneider. The FY26 restructuring involves $2.1B in costs, including 20-30k layoffs, algorithm changes, H1B usage, and scrutiny over Nashville's $240M incentives amid low job creation and AI concerns.

How has Oracle's stock performed recently and what are the valuation debates?

Oracle's stock rose +3.15% to $183.16 with an options volume spike, rebounding +3.31% on Apr 21. Bears value it at $112 via DCF compared to $244 current valuation and some $400 price targets.

ORCL +3.15% to $183.16 (options vol spike)/Apr21 +3.31% rebound/Bloom +22% 2.8GW/>10GW/$156B power/$35B DCs; $45-50B financing/CFO Maxson $26M (ex-Schneider); FY26 restruct $2.1B/20-30k layoffs/algo/H1B/Nashville $240M incentives low jobs AI scrutiny; Oracle Health (ex-Cerner) divestiture rumors amid infra burden for balance sheet relief; bears DCF $112 vs $244 valuation/$400 PTs.

Sources (2)
Updated Apr 22, 2026